Fever Infection
- Manufacturer
- Newton Laboratories, Inc.
- Effective date
- 2011-03-01
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-06-01 02:05:04
Label at a glance#
ProductFever Infection
Active ingredientInfluenza A Virus, Aconitum Napellus, Arsenic Trioxide, Atropa Belladonna, Bryonia Alba Root, Camphor (natural), Artemisia Cina Pre-flowering Top, Cinchona Officinalis Bark, Eupatorium Perfoliatum Flowering Top, Gelsemium Sempervirens Root, Calcium Sulfide, Strychnos Ignatii Seed, Sodium Chloride, Strychnos Nux-vomica Seed, Phosphorus, Pulsatilla Vulgaris, Salix Nigra Bark, Veratrum Viride Root, Matricaria Recutita, Echinacea, Unspecified, Goldenseal, Ferrosoferric Phosphate, Influenza B Virus
Label structure10 sections
Contacts and useful links#
Websitewww.newtonlabs.net
www.newtonlabs.net
www.newtonlabs.netLabel contents#
Full prescribing information#
INDICATIONS & USAGE SECTION
Fever - Infection Formulated for associated symptoms such as chills, aches, sweating, fatigue, nausea and loss of appetite.
DOSAGE & ADMINISTRATION SECTION
Directions: Children, ages 0 to 11, give 3 pellets orally (ages 12 and up, give 6 pellets) as needed or as directed by a healthcare professional. Under age 2, crush or dissolve pellets in purified water. Sensitive persons begin with 1 pellet and gradually increase to full dose. Warning: If symptoms become severe or fever persists for more than 48 hours, consult a licensed health care professional.
OTC - ACTIVE INGREDIENT SECTION
Influenzinum 30x, Aconitum nap. 15x, Arsenicum alb. 15x, Belladonna 15x, Bryonia 15x, Camphora 15x, Cina 15x, Cinchona 15x, Eupatorium perf. 15x, Ferrum phosphoricum 15x, Gelsemium 15x, Hepar sulph. calc. 15x, Ignatia 15x, Nat. mur.15x, Nux vom. 15x, Phosphorus 15x, Pulsatilla 15x, Salix nigra 15x, Veratrum viride 15x, Chamomilla 3x, Echinacea 3x, Hydrastis 3x.
OTC - PURPOSE SECTION
Formulated for associated symptoms such as chills, aches, sweating, fatigue, nausea and loss of appetite.
INACTIVE INGREDIENT SECTION
Inactive Ingredients: Gluten-free, non-GMO, beet-derived sucrose pellets.
QUESTIONS SECTION
www.newtonlabs.net Newton Laboratories, Inc. FDA Est # 1051203 - Conyers, GA 30012
Questions? 1.800.448.7256
WARNINGS SECTION
Warning: Do not use if tamper - evident seal is broken or missing. Consult a licensed healthcare professional if p. regnant, nursing or if symptoms worsen or persist for more than a few days. Keep out of reach of children.
OTC - PREGNANCY OR BREAST FEEDING SECTION
Consult a licensed healthcare professional if pregnant, nursing or if symptoms worsen or persist for more than a few days.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children.
PACKAGE LABEL
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 55714-1703-0 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-002e-f424-e053-dadaa90a57ce | Fever - Infection |
| 55714-1703-1 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-002e-f424-e053-dadaa90a57ce | Fever - Infection |
| 55714-1703-2 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-002e-f424-e053-dadaa90a57ce | Fever - Infection |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 55714-1703-0 | Fever Infection | 7.08 g in 1 BOTTLE, GLASS | PELLET | 7.08 | 1 | |
| 55714-1703-1 | Fever Infection | 28.35 g in 1 BOTTLE, GLASS | PELLET | 28.35 | 1 | |
| 55714-1703-2 | Fever Infection | 56.7 g in 1 BOTTLE, GLASS | PELLET | 56.7 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 55714-1703 | FEVER INFECTION (INFLUENZINUM, ACONITUM NAP., ARSENICUM ALB., BELLADONNA, BRYONIA, CAMPHORA, CINA, CINCHONA, EUPATORIUM PERF., FERRUM PHOSPHORICUM, GELSEMIUM, HEPAR SULPH. CALC., IGNATIA, NAT. MUR., NUX VOM., PHOSPHORUS, PULSATILLA, SALIX NIGRA,VERATRUM VIRIDE, CHAMOMILLA, ECHINACEA, HYDRASTIS.) PELLET [NEWTON LABORATORIES, INC.] | 1 | Legacy NDC, 3 package rows | 20131022_41d776b5-0d2d-d599-b6b1-79e5b19b1666.zip |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Aconitum Napellus | ACTIVE INGREDIENT | U0NQ8555JD | 1 | |
| Arsenic Trioxide | ACTIVE INGREDIENT | S7V92P67HO | 1 | |
| Artemisia Cina Pre-flowering Top | ACTIVE INGREDIENT | 28M1820ACT | 1 | |
| Atropa Belladonna | ACTIVE INGREDIENT | WQZ3G9PF0H | 1 | |
| Bryonia Alba Root | ACTIVE INGREDIENT | T7J046YI2B | 1 | |
| Calcium Sulfide | ACTIVE INGREDIENT | 1MBW07J51Q | 1 | |
| Camphor (natural) | ACTIVE INGREDIENT | N20HL7Q941 | 1 | |
| Cinchona Officinalis Bark | ACTIVE INGREDIENT | S003A158SB | 1 | |
| Echinacea, Unspecified | ACTIVE INGREDIENT | 4N9P6CC1DX | 1 | |
| Eupatorium Perfoliatum Flowering Top | ACTIVE INGREDIENT | 1W0775VX6E | 1 | |
| Ferrosoferric Phosphate | ACTIVE INGREDIENT | 91GQH8I5F7 | 1 | |
| Gelsemium Sempervirens Root | ACTIVE INGREDIENT | 639KR60Q1Q | 1 | |
| Goldenseal | ACTIVE INGREDIENT | ZW3Z11D0JV | 1 | |
| Influenza A Virus | ACTIVE INGREDIENT | R9HH0NDE2E | 1 | |
| Influenza B Virus | ACTIVE INGREDIENT | 1314JZ2X6W | 1 | |
| Matricaria Recutita | ACTIVE INGREDIENT | G0R4UBI2ZZ | 1 | |
| Phosphorus | ACTIVE INGREDIENT | 27YLU75U4W | 1 | |
| Pulsatilla Vulgaris | ACTIVE INGREDIENT | I76KB35JEV | 1 | |
| Salix Nigra Bark | ACTIVE INGREDIENT | QU52J3A5B3 | 1 | |
| Sodium Chloride | ACTIVE INGREDIENT | 451W47IQ8X | 1 | |
| Strychnos Ignatii Seed | ACTIVE INGREDIENT | 1NM3M2487K | 1 | |
| Strychnos Nux-vomica Seed | ACTIVE INGREDIENT | 269XH13919 | 1 | |
| Veratrum Viride Root | ACTIVE INGREDIENT | 197B3Q7T5Q | 1 | |
| Aconitum Napellus | ACTIVE MOIETY | U0NQ8555JD | 1 | |
| Arsenic Cation (3+) | ACTIVE MOIETY | C96613F5AV | 1 | |
| Artemisia Cina Pre-flowering Top | ACTIVE MOIETY | 28M1820ACT | 1 | |
| Atropa Belladonna | ACTIVE MOIETY | WQZ3G9PF0H | 1 | |
| Bryonia Alba Root | ACTIVE MOIETY | T7J046YI2B | 1 | |
| Calcium Sulfide | ACTIVE MOIETY | 1MBW07J51Q | 1 | |
| Camphor (natural) | ACTIVE MOIETY | N20HL7Q941 | 1 | |
| Chloride Ion | ACTIVE MOIETY | Q32ZN48698 | 1 | |
| Cinchona Officinalis Bark | ACTIVE MOIETY | S003A158SB | 1 | |
| Echinacea, Unspecified | ACTIVE MOIETY | 4N9P6CC1DX | 1 | |
| Eupatorium Perfoliatum Flowering Top | ACTIVE MOIETY | 1W0775VX6E | 1 | |
| Ferrosoferric Phosphate | ACTIVE MOIETY | 91GQH8I5F7 | 1 | |
| Gelsemium Sempervirens Root | ACTIVE MOIETY | 639KR60Q1Q | 1 | |
| Goldenseal | ACTIVE MOIETY | ZW3Z11D0JV | 1 | |
| Influenza A Virus | ACTIVE MOIETY | R9HH0NDE2E | 1 | |
| Influenza B Virus | ACTIVE MOIETY | 1314JZ2X6W | 1 | |
| Matricaria Recutita | ACTIVE MOIETY | G0R4UBI2ZZ | 1 | |
| Phosphorus | ACTIVE MOIETY | 27YLU75U4W | 1 | |
| Pulsatilla Vulgaris | ACTIVE MOIETY | I76KB35JEV | 1 | |
| Salix Nigra Bark | ACTIVE MOIETY | QU52J3A5B3 | 1 | |
| Strychnos Ignatii Seed | ACTIVE MOIETY | 1NM3M2487K | 1 | |
| Strychnos Nux-vomica Seed | ACTIVE MOIETY | 269XH13919 | 1 | |
| Veratrum Viride Root | ACTIVE MOIETY | 197B3Q7T5Q | 1 | |
| Sucrose | INACTIVE INGREDIENT | C151H8M554 | 1 |
Products#
Every source-derived product name is available through these pages.
- Fever Infection
- Influenzinum, Aconitum nap., Arsenicum alb., Belladonna, Bryonia, Camphora, Cina, Cinchona, Eupatorium perf., Ferrum phosphoricum, Gelsemium, Hepar sulph. calc., Ignatia, Nat. mur., Nux vom., Phosphorus, Pulsatilla, Salix nigra,Veratrum viride, Chamomilla, Echinacea, Hydrastis.
- Influenza A Virus
- Aconitum Napellus
- Arsenic Trioxide
- Arsenic Cation (3+)
- Atropa Belladonna
- Bryonia Alba Root
- Camphor (natural)
- Artemisia Cina Pre-flowering Top
- Cinchona Officinalis Bark
- Eupatorium Perfoliatum Flowering Top
- Gelsemium Sempervirens Root
- Calcium Sulfide
- Strychnos Ignatii Seed
- Sodium Chloride
- Chloride Ion
- Strychnos Nux-vomica Seed
- Phosphorus
- Pulsatilla Vulgaris
- Salix Nigra Bark
- Veratrum Viride Root
- Matricaria Recutita
- Echinacea, Unspecified
- Goldenseal
- Ferrosoferric Phosphate
- Influenza B Virus
- Sucrose
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 55714-1703 | 55714-1703-1, 55714-1703-2, 55714-1703-0 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Sucrose | SUCROSE | C151H8M554 | TROCHE / ORAL | NA | ||
| Sucrose | SUCROSE | C151H8M554 | INJECTABLE, LIPOSOMAL / INTRAVENOUS | 7560 mg | ||
| Sucrose | SUCROSE | C151H8M554 | TABLET / BUCCAL | 109 mg | ||
| Sucrose | SUCROSE | C151H8M554 | TABLET, COATED / ORAL | 516.42 mg | ||
| Sucrose | SUCROSE | C151H8M554 | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / SUBCUTANEOUS | 308 mg | ||
| Sucrose | SUCROSE | C151H8M554 | ELIXIR / ORAL | 18000 mg | ||
| Sucrose | SUCROSE | C151H8M554 | SUPPOSITORY / RECTAL | NA | ||
| Sucrose | SUCROSE | C151H8M554 | CONCENTRATE / ORAL | 4800 mg | ||
| Sucrose | SUCROSE | C151H8M554 | TABLET, DELAYED RELEASE / ORAL | 295.33 mg | ||
| Sucrose | SUCROSE | C151H8M554 | POWDER / ORAL | 27768 mg | ||
| Sucrose | SUCROSE | C151H8M554 | TABLET, EXTENDED RELEASE / ORAL | 284.54 mg | ||
| Sucrose | SUCROSE | C151H8M554 | INJECTION, EMULSION / INTRAVENOUS | 970 mg | ||
| Sucrose | SUCROSE | C151H8M554 | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 2000 mg | ||
| Sucrose | SUCROSE | C151H8M554 | TABLET / ORAL | 4249 mg | ||
| Sucrose | SUCROSE | C151H8M554 | INJECTION, POWDER, FOR SUSPENSION / INTRAVENOUS | 900 mg | ||
| Sucrose | SUCROSE | C151H8M554 | INJECTION / SUBCUTANEOUS | 47.75 mg | ||
| Sucrose | SUCROSE | C151H8M554 | SOLUTION / ORAL | 70000 mg | ||
| Sucrose | SUCROSE | C151H8M554 | INJECTION, SUSPENSION, LIPOSOMAL / INTRAVENOUS | 9.4 %w/v | ||
| Sucrose | SUCROSE | C151H8M554 | TROCHE / BUCCAL | NA | ||
| Sucrose | SUCROSE | C151H8M554 | GRANULE / ORAL | NA | ||
| Sucrose | SUCROSE | C151H8M554 | LOZENGE / TRANSMUCOSAL | 1255 mg | ||
| Sucrose | SUCROSE | C151H8M554 | SYRUP / ORAL | 46400 mg | ||
| Sucrose | SUCROSE | C151H8M554 | GRANULE, FOR SUSPENSION, EXTENDED RELEASE / ORAL | 18790 mg | ||
| Sucrose | SUCROSE | C151H8M554 | TABLET / SUBLINGUAL | 109 mg | ||
| Sucrose | SUCROSE | C151H8M554 | DROPS / ORAL | NA | ||
| Sucrose | SUCROSE | C151H8M554 | LIQUID / ORAL | 37500 mg | ||
| Sucrose | SUCROSE | C151H8M554 | SUSPENSION/ DROPS / ORAL | 3750 mg | ||
| Sucrose | SUCROSE | C151H8M554 | POWDER, FOR SOLUTION / ORAL | 38666 mg | ||
| Sucrose | SUCROSE | C151H8M554 | CAPSULE, DELAYED RELEASE / ORAL | 955 mg | ||
| Sucrose | SUCROSE | C151H8M554 | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 119.12 mg | ||
| Sucrose | SUCROSE | C151H8M554 | WAFER / ORAL | 155.2 mg | ||
| Sucrose | SUCROSE | C151H8M554 | CAPSULE, COATED PELLETS / ORAL | 59.8 mg | ||
| Sucrose | SUCROSE | C151H8M554 | CAPSULE, COATED, EXTENDED RELEASE / ORAL | 86 mg | ||
| Sucrose | SUCROSE | C151H8M554 | LOZENGE / BUCCAL | NA | ||
| Sucrose | SUCROSE | C151H8M554 | POWDER, FOR SUSPENSION / ORAL | 40017 mg | ||
| Sucrose | SUCROSE | C151H8M554 | INJECTION / INTRAVENOUS | 1950 mg | ||
| Sucrose | SUCROSE | C151H8M554 | PASTILLE / ORAL | 426 mg | ||
| Sucrose | SUCROSE | C151H8M554 | TABLET, CHEWABLE / ORAL | 7258 mg | ||
| Sucrose | SUCROSE | C151H8M554 | GRANULE, FOR SOLUTION / ORAL | 42596 mg | ||
| Sucrose | SUCROSE | C151H8M554 | SUSPENSION / ORAL | 48209 mg | ||
| Sucrose | SUCROSE | C151H8M554 | INJECTION, SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS | 1 mg | ||
| Sucrose | SUCROSE | C151H8M554 | INJECTION, SOLUTION / INTRAVENOUS | NA | ||
| Sucrose | SUCROSE | C151H8M554 | SUSPENSION, EXTENDED RELEASE / ORAL | 5400 mg | ||
| Sucrose | SUCROSE | C151H8M554 | GRANULE, FOR SUSPENSION / ORAL | 31885 mg | ||
| Sucrose | SUCROSE | C151H8M554 | CAPSULE, EXTENDED RELEASE / ORAL | 619 mg | ||
| Sucrose | SUCROSE | C151H8M554 | CAPSULE / ORAL | 3568 mg | ||
| Sucrose | SUCROSE | C151H8M554 | SOLUTION / RECTAL | 35.42 %w/v | ||
| Sucrose | SUCROSE | C151H8M554 | TABLET, FILM COATED / ORAL | 145 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 727785e6-1e8e-102b-c648-7f20cd14759c | 41d776b5-0d2d-d599-b6b1-79e5b19b1666 | 2011-03-01 | Warnings | 727785e6-1e8e-102b-c648-7f20cd14759c 41d776b5-0d2d-d599-b6b1-79e5b19b1666 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.